Article
Bracco Highlights at RSNA 2023
Join Bracco at RSNA 2023 to explore our latest innovations in medical imaging, including AI-driven tools and advanced contrast agents.

Article

Article
Data Reinforcing Efficacy and Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions Published in Radiology
The results of the multicenter, international PROMISE clinical trial demonstrate that gadopiclenol provides similar lesion visualization and contrast enhancement at a gadolinium dose of 0.05 mmol/kg versus a full dose of gadobutrol (0.1 mmol/kg).

Article
Funding the Future of Radiology¹
With an over $1.8 million investment in radiology research, Bracco Diagnostics Inc. actively supports the advancement of the field by ensuring that 34 early-career radiological investigators have access to much-needed funding.

Article
Bracco: Driving the Future of Radiology Innovation
Explore how Bracco's $1.8M investment in radiology innovation resulted in 59 manuscripts, six patents, two startup businesses, and additional grant funding.

Article
Recognizing Radiology Leaders of the Future
Bracco celebrates 34 radiology professionals shaping the future of medical imaging through innovation, education, and collaboration worldwide.

Article
What AI Means for the Future of Medical Imaging
Explore the role of AI in transforming medical imaging, improving diagnostic accuracy, and streamlining radiology workflows for better patient outcomes.

Article
Bracco Imaging and Subtle Medical Global Agreement
Bracco signs global agreement with Subtle Medical to integrate AI-driven image enhancement into diagnostic workflows for improved accuracy.

Article
Vueway® Earns Positive CHMP Opinion for MRI Contrast
Learn about Vueway® (gadopiclenol) receiving a positive CHMP opinion, moving closer to full European approval for advanced MRI contrast imaging.

Article
Bracco Spin: 20 Years of Innovation
Bracco commemorates two decades of success with Bracco Spin by announcing plans to expand production capacity.
